Agarose gel serum protein electrophoresis in cats with and without lymphoma and preliminary results of tandem mass fingerprinting analysis by Gerou-Ferriani, M. et al.
  
 
 
 
 
 
 
 
 
Gerou-Ferriani, M., McBrearty, A.R., Burchmore, R.J., Jayawardena, 
K.G.I., Eckersall, P.D., and Morris, J.S. (2011) Agarose gel serum protein 
electrophoresis in cats with and without lymphoma and preliminary results 
of tandem mass fingerprinting analysis.Veterinary Clinical Pathology, 40 
(2). pp. 159-173. ISSN 0275-6382 
 
Copyright © 2011 Wiley Blackwell  
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
Content must not be changed in any way or reproduced in any format 
or medium without the formal permission of the copyright holder(s) 
 
 
When referring to this work, full bibliographic details must be given 
 
 
 
http://eprints.gla.ac.uk/44666/ 
 
 
 
  Deposited on: 07 March 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
Agarose gel serum protein electrophoresis in cats with and 
without lymphoma and preliminary results of tandem mass 
fingerprinting analysis  
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
 
Short title: SPE and proteomics in cats with and without lymphoma 
Magda Gerou-Ferriani1, Alix R. McBrearty
1
, Richard J. Burchmore2, Kamburapola GI. 
Jayawardena2, P. David Eckersall
3
, Joanna S. Morris1 
 
1 Division of Companion Animal Sciences, Faculty of Veterinary Medicine, University of Glasgow, 
Bearsden Road, Glasgow, G61 1QH, UK 
2 Sir Henry Wellcome Functional Genomics Facility, Faculty of Biomedical and Life Sciences, 
University of Glasgow, University Avenue, Glasgow, G12 8QQ, UK 
3 Division of Animal Production & Public Health, Faculty of Veterinary Medicine, University of 
Glasgow, Bearsden Road, Glasgow, G61 1QH, UK 
 
Correspondence: 
Dr Joanna S. Morris 
Faculty of Veterinary Medicine 
University of Glasgow 
Bearsden Road 
Glasgow  
G61 1QH 
E-mail: j.morris@vet.gla.ac.uk  
Key words: electrophoresis, proteomics, lymphoma, lymphoid neoplasia, feline, acute phase 
proteins
 1
 26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
 
Abstract  
Background: Serum electrophoretic profiles in cats are poorly characterized with respect to the 
protein components of the globulin fractions, and interpretation of the electrophoretograms has 
routinely been done in ignorance of the identity of the proteins found within each fraction.  
Objectives: To compare the protein fractions from serum protein electrophoresis (SPE) in 
healthy cats and those with lymphoma and to confirm some component proteins in the major 
fractions after feline SPE, using tandem mass fingerprinting analysis (TMFA).  
Methods: Total protein was measured and agarose gel SPE performed on blood collected from 
14 healthy cats and 14 with lymphoma. The absolute protein concentration within each fraction 
was compared between the two groups. Bands corresponding to the SPE fractions were excised 
from two controls and a lymphoma cat and analysed by liquid chromatography coupled to mass 
spectrometry. Results were compared to sequences in the NCBI protein database. 
Results: Median albumin concentrations were significantly decreased in lymphoma cats and 
median beta globulin concentrations were elevated. Narrow electrophoretic spikes were present 
in the beta/gamma fraction in 3 lymphoma cats. Following TMFA, multiple proteins were identified 
from each fraction and their mobility agreed with results from previous studies generated using 
alternative techniques. Inter–alpha (globulin) inhibitor 4 was identified in feline serum for the first 
time.  
Conclusions: Cats with lymphoma had lower median albumin and higher beta globulin 
concentrations than healthy cats. Despite the limitations of 1D agarose gel SPE, TMFA provided 
preliminary data to confirm the protein components of the various fractions.  
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Serum protein electrophoresis (SPE) on agarose gels has been a technique used in veterinary 
clinical pathology for several decades for the characterization of serum protein into its main 
fractions and can provide valuable information in the diagnosis of disease in animals. Most 
reports in cats regarding SPE are focused on infectious diseases such as Feline Infectious 
Peritonitis (FIP),1,2,3,4 Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV).5 In 
clinical feline medicine it may also be used in the investigation of hyperproteinemias to 
differentiate monoclonal and polyclonal gammopathies.6,7 In humans, characteristic 
electrophoresis patterns have been found for a variety of conditions including acute inflammation, 
chronic inflammation and malignant tumors.8   
 
The protein fractions of serum are defined by the electrophoretic separation into albumin, which 
has the highest anodal mobility and the α−1, α−2 , β−1, β−2 and γ globulin fractions in order of 
decreasing anodal mobility. In the serum of normal cats, the globulin fractions have been 
subdivided further into α−1a, α−1b, α−2a, α−2b, β−1 and β−2 globulins by investigators using 
high resolution agarose electrophoresis systems,9,10 however, this is not routinely performed in 
diagnostic laboratories.  Although the method has been used for many years, the identity of the 
proteins which comprise the globulin fractions in cats has not been extensively investigated and 
interpretation of the results of feline serum electrophoretograms has largely been in ignorance of 
the identity of the proteins found within each fraction. Immunoelectrophoresis of the 
plasma/serum of healthy cats has identified the location of some, but not all of the plasma/serum 
proteins on the electrophoretic profile.11,12 This technique is limited by the availability of 
appropriate species-specific antibodies. It is generally assumed that on SPE, the serum proteins 
in other mammals will behave similarly to those in human serum, where this technique has been 
characterized more fully.13,14 
 
There has recently been a rapid development in the proteomic techniques which seek to identify 
proteins following separation from a complex mixture. This process involves the use of specific 
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protein cleaving agents, usually trypsin, to generate a set of peptides that can be characterized 
by mass spectrometry. Separation of peptides by liquid chromatography, prior to mass 
spectrometry and tandem mass spectrometry can enable both amino acid composition and 
sequence to be inferred for many peptides. Matching of this data to in silico generated peptide 
and peptide fragmentation databases can allow identification of proteins of interest, providing that 
genome data is available. This tandem mass fingerprinting analysis (TMFA) approach can be 
used to characterize proteins separated by 1-Dimensional polyacrylamide gel electrophoresis 
(PAGE) and is often able to resolve components of bands that are detected by this technique.15,16 
2-Dimensional PAGE allows even better separation of the individual proteins, resulting in more 
precise determination of the components in each feature (spot) after TMFA, however currently, 
neither technique is routinely used in clinical laboratories. 1-Dimensional agarose gel 
electrophoresis (the standard method of analysis for clinical samples with suspected 
dysproteinemia) results in less complete separation of the proteins hence each band is likely to 
contain a mixture of proteins. However, agarose gel electrophoresis does have some advantages 
such as reduced loss of highly charged or hydrophobic proteins which can occur during 
isoelectric focusing and therefore does have a valid role in proteomic analysis. Furthermore 
TMFA has recently been used to identify a prominent α-globulin peak on the SPE profile of 
birds.17  
 
Lymphoma is the most common hemopoietic tumor in cats.18 SPE has been used to identify 
monoclonal gammopathies in cats with lymphoma.19,20  It is likely that other abnormalities in the 
electrophoretic profile of cats with lymphoma occur, possibly due to changes in acute phase 
protein  (APP) concentrations such as alpha 1-acid glycoprotein (AGP),21,22 however, no 
characteristic pattern has been described. 
 
This study was designed to analyze the protein fractions from SPE in healthy cats and those with 
lymphoid neoplasia and identify if the globulin fractions are subject to consistent changes in 
relation to neoplasia. Proteomic analysis was used to identify the component proteins which 
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make up the major fractions of feline serum following SPE on agarose gels and thus improve the 
interpretation/utility of feline electrophoretograms. Although bands were excised from both 
healthy cats, and  lymphoma cats to increase the number of proteins identified in the study,  the 
limitations in protein separation with agarose gels outlined above as well as the small number of 
cases analysed, meant that the comparison between healthy and lymphoma cats was incomplete 
and only very preliminary.  
 
Materials and methods 
Blood samples (3-5ml) were collected from 16 clinically healthy cats and 16 cats with suspected 
lymphoid neoplasia between November 2006 and February 2009. Written informed consent was 
obtained from all owners and the study protocol was approved by the Ethics and Welfare 
committee of the University of Glasgow. The control group consisted of healthy, vaccinated and 
wormed cats from 2 different first opinion practices in Rome (n=12) which were presented for 
FeLV and FIV testing prior to routine booster vaccination (against Feline Herpes Virus, Feline 
Calici Virus, Feline Panleukopenia Virus and FeLV) and from the University of Glasgow Small 
Animal Hospital feline blood donor registry (n=4) that were used for cross-matching and blood 
transfusions during the period of the study. All control cats had been vaccinated against the 
above diseases (except FIV) within the preceding 12 months. They underwent a physical 
examination, FeLV and FIV testing and biochemical evaluation (the latter performed at the 
Veterinary Diagnostic Service of the Faculty of Veterinary Medicine, University of Glasgow) and 
cats with abnormal biochemical results (outwith the laboratory reference range for any analyte) 
were excluded from the study (n=2). Acute phase proteins (serum amyloid A (SAA), α1 acid 
glycoprotein (AGP) and haptoglobin (Hp)) were measured in stored samples using previously 
established methods, 4, 23, 24  for 11 (Hp and AGP) and 13 (SAA) cats respectively. 
 
Cats with suspected lymphoid neoplasia referred to the Small Animal Hospital, University of 
Glasgow (U.K.) for confirmation of the diagnosis, staging and treatment were eligible for inclusion 
in the study (lymphoma group, n=16). Blood was collected prior to treatment. All lymphoma cats 
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underwent routine clinical staging including a complete blood count, biochemistry profile, FeLV 
and FIV testing, abdominal ultrasound and thoracic radiography. Acute phase proteins (Hp, AGP, 
and SAA) were measured on stored samples as above. When appropriate, additional diagnostic 
investigations were performed at the discretion of the clinician. Samples from cats which had 
received chemotherapy prior to sampling were excluded from the study (n=2). 
 
Blood was collected into serum tubes (Sarstedt AG & Co, Germany) and allowed to clot at room 
temperature (20-25°C) before separation of serum by centrifugation (J6-MI Centrifuge, Beckman 
Coulter, Ireland) at 3000g for 5 minutes. The serum samples were stored at -20°C for up to 2 
years before analysis when they were gently thawed, homogenized by vortexing and assayed. 
 
The total protein concentration was determined by the biuret method using an automated 
analyzer (Olympus AU640, Olympus, USA) as previously described.25 The protein calibrator was 
prepared from human serum (Olympus System calibrator 66300, Olympus Life Science Research 
Europa, Germany).  
 
Electrophoresis was performed using an agarose gel electrophoresis system (The Paragon SPE 
Kit, Beckman Coulter, USA) according to the manufacturer’s instructions except that to increase 
the protein concentration (in order to increased the sensitivity of the TMFA), the samples were not 
diluted prior to SPE. Four microliters of each serum sample were applied to preformed, numbered 
sample wells on the agarose gel. Each gel could accommodate up to 10 samples. Control serum 
PathonormTM H (SERO AS, Norway) was included on each gel used. A combination of feline 
control samples and lymphoma samples were run on each gel. The gels were electrophoresed for 
25 minutes at a constant voltage of 100V in 5,5 diethylbarbituric acid (B-2 Barbital Buffer, 
Beckman Coulter, USA). After electrophoresis, the gels were fixed in acid alcohol (20% acetic 
acid and 30% methanol, Fisher Scientific UK Ltd, UK) and dried at 37°C for 18-24 hours.  Then 
they were stained in Paragon Blue Stain (0.5% w/v solution) (Beckman Coulter, USA) for 3 
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minutes, and after destaining in 5% acetic acid solution (Fisher Scientific UK Ltd, UK) and acid 
alcohol solution, were dried completely.  
 
The stained gels were scanned using a flat bed scanner (UMAX PowerLock III, UMAK UK Ltd, 
UK) and saved as grayscale TIF files. Computer software (TotalLab Life Science Analysis 
Essentials, Nonlinear dynamics, UK) was then used to identify the lanes, subtract background 
and obtain a densitometric trace (electrophoretogram) for each cat (Figure 1). Protein fraction 
(and sub-fraction) identification and labeling using the software, followed visual examination of 
each electrophoretogram by three people (MGF, AM, PDE) to reach a consensus on the fraction 
positions. The relative protein concentration within each fraction was determined by the software 
as the percentage of optical absorbance of that fraction. The absolute concentration (g/l) of each 
fraction was then calculated by multiplying the relative protein concentration of each fraction by 
the total serum protein concentration. 
 
Normality was assessed by visual inspection of box and whisker plots of the data. On this basis, 
non-parametric tests were used. The median ages, median number of electrophoretic peaks 
identified, median total protein and median absolute protein fraction concentrations (g/l) as well 
as APP concentrations were compared between the control cats and the lymphoma cats using a 
Mann-Whitney U test. Significance was set at p<0.05. GraphPad Prism 5 for Windows (GraphPad 
Software Inc, USA) was used for statistical analyses.  
 
The gels were examined and two control cats with unremarkable electrophoretograms were 
selected for TMFA. From these cats, bands corresponding to the identified globulin fractions 
(α−1a, α−1b, α−2a, α−2b, β−1, β−2 and γ) were excised for analysis by proteomics. The albumin 
fraction was also excised from one cat for further analysis although the main focus of the study 
was the globulins. In addition, all distinguishable globulin fractions (α−1a, α−1b, α−2, β and γ) 
were individually excised from one cat with lymphoma. This cat’s electrophoretogram was 
selected as it had no particularly strong bands on visual inspection of the gel,  Four other 
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lymphoma cases had bands of strong relative intensities which looked to be of potential clinical 
significance and these four bands were also excised for proteomic analysis.  
 
The excised gel bands were washed (with shaking) in 100 mM ammonium bicarbonate (GE 
Healthcare, UK) for 1 hour at room temperature, followed by a second wash in 50% 
acetonitrile/100mM ammonium bicarbonate (GE Healthcare, UK). Proteins were reduced with 3 
mM dithiothreitol in 100mM ammonium bicarbonate (GE Healthcare, UK) for 30 min at 60°C, 
followed by alkylation with 10 mM iodoacetamide (GE Healthcare, UK) for 30 min in the dark at 
room temperature. The gel pieces were washed with 50% acetonitrile/100mM ammonium 
bicarbonate, shaking for 1 hour at room temperature, then dehydrated by incubation with 0.1 mL 
acetonitrile for 10 min at room temperature. Gel pieces were dried to completion under vacuum, 
then rehydrated with a sufficient volume of trypsin (Promega sequencing grade, 2 mg/mL in 25 
mM ammonium bicarbonate (Promega Ltd, UK)) to cover the gel pieces. Digestion was 
performed at 37°C overnight. The liquid was then transferred to a fresh tube, and gel pieces 
washed 10 min with a similar volume of 50% acetonitrile. This wash was pooled with the first 
extract, and the tryptic peptides dried to completion. 
 
Tryptic peptides were solubilized in 0.5% formic acid (GE Healthcare, UK) and fractionated on a 
nanoflow high performance liquid chromatography system (FAMOS/SwitchosTM/UltiMate, LC 
Packings, Dionex, USA) before being analysed by electrospray ionisation (ESI) mass 
spectrometry on a Q-STAR® Pulsar i hybrid MS/MS System (Applied Biosystems Inc, USA). 
Peptide separation was performed on a Pepmap C18 reversed phase column (LC Packings, 
Dionex, USA), using a 5 - 85% v/v acetonitrile gradient (in 0.5% v/v formic acid) run over 45 
minutes. The flow rate was maintained at 0.2 μl/min. Mass spectrometric analysis was performed 
using a 3 second survey MS scan followed by up to four MS/MS analyses of the most abundant 
peptides (3 seconds per peak) in Information Dependent Acquisition (IDA) mode, choosing 2+ to 
4+ ions above  threshold of 30 counts, with dynamic exclusion for 120s. 
 
 8
216 
217 
218 
219 
220 
221 
222 
223 
224 
225 
226 
227 
228 
229 
230 
231 
232 
233 
234 
235 
236 
237 
238 
239 
240 
241 
242 
243 
Data generated from the Q-STAR® Pulsar i hybrid mass spectrometer was analysed using 
Analyst QS (v1.1) software (Applied Biosystems Inc, USA) and the automated Mascot Daemon 
server (v2.1.06) (Matrix Science Ltd, UK). The Mascot search engine was used to compare data 
against sequences in the current National Center for Biotechnology Information (NCBI) protein 
database, restricting searches to mammalian sequences. In all cases, variable methionine 
oxidation was allowed in searches and carbamidomethylation of cysteines was selected as a 
fixed modification. An MS tolerance of 1.2 Da for MS and 0.4 Da for MS/MS analysis was used. 
Peptides identified with a MOWSE score greater than 48 (p<0.05) were included as this was the 
identity threshold above which identified parent proteins were considered valid. When proteins 
matched sequences from multiple species, only the species with the highest combined peptide 
MOWSE score was included in the table unless a match with a MOWSE score >48 with Felis 
catus was noted, when this was included instead.          
 
Results 
Animals 
Serum was collected from 16 control cats based on unremarkable physical examinations but two 
were subsequently excluded for marked azotemia (n=1) or low total protein and albumin 
concentrations (n =1). All 14 included control cats were domestic shorthairs (DSH) with a median 
age of 4 years (age unknown for three cats, range 0.3 to 11 years) and all were FeLV and FIV 
negative.  
 
Fourteen cats with confirmed lymphoid neoplasia were included in the study (2 additional cats 
were excluded as they had received chemotherapy prior to sampling). The median age of the 
lymphoma group was 8 years (range 0.67 to 16 years). Twelve cats were DSH, one was a 
domestic longhair and one was an oriental shorthair. The cats were presented for a variety of 
reasons including: lethargy (n=2), inappetance/anorexia (n=2), vomiting (n=3), a palpable 
abdominal mass (n=4), enlarged peripheral lymph nodes (n=3), dyspnoea (n=4), wheezing (n=1) 
and coughing (n=1). Five cats had more than one reason for presentation. The cats had had 
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clinical signs for 1 to 8 weeks prior to presentation (unknown for 3 cats). Details of virus status 
and the lymphoma site, immunophenotype and method of diagnosis are given in table 1.  In all 
cases, the observed predominant cell type was lymphoblastic not lymphocytic, with coarse, 
hyperchromatic nuclei, prominent nucleoli, and moderate to high mitotic rate frequently reported. 
Despite their heterogeneity in anatomical site and clinical presentation, all lymphomas were 
therefore considered high grade for clinical treatment. 
 
There was no significant difference in the median age of the control and lymphoma groups 
(p=0.07). The median total protein results for the control group was 74.5g/l (range: 67.0 to 
86.0g/l) and was not significantly different from the median total protein for the lymphoma group 
(74.5g/l, range: 53.0 to 89.0g/l). One cat in the lymphoma group (lymphoma cat 12, figure 2d) 
was hyperproteinemic (89g/l). APP measurements were obtained for all lymphoma cats and 11 
(Hp and AGP) or 13 (SAA) control cats. Median Hp (5.0g/l) and AGP (1.4g/l) were significantly 
higher in the lymphoma cats (p=0.005, p=0.008) but SAA (median 1.6mg/l) was not significantly 
different (p=0.189) than in the control group in which the median concentrations were 1.6 g/l for 
Hp, 0.9 g/l for AGP and 1.2 mg/l for SAA.. 
 
Protein electrophoresis 
Following densitometer scanning of the electrophoretograms, a minimum of 5 peaks (albumin, α-
1, α-2, β and γ) were identified in each cat. In the majority of cats (24/28), α-1 globulins could be 
further divided into α-1a and -1b fractions. In seven cats, 8 peaks could be identified (albumin, α-
1a, α-1b, α-2a, α-2b, β-1, β-2 and γ) (figure 1). There was no significant difference between the 
median number of peaks identified in the control cats (6 peaks) and the lymphoma cats (7 peaks) 
(p=0.05). The relative and absolute median values of the protein fractions and the 
albumin:globulin ratios for the control cats and lymphoma cats are shown (table 2). A statistically 
significant difference between the lymphoma cats and the control cats was found for the absolute 
median value of albumin (p=0.046) and β globulin (p=0.018) concentrations. Other comparisons 
between the groups were not significantly different.  
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On visual inspection of the gels, there were no consistent differences between lymphoma and 
control samples but bands with markedly increased intensity were noted in lymphoma cats in α 
globulin (1 sample), β globulin (2 samples) and γ globulin (1 sample) (bands N, O, P and Q, 
Figure 2).  
 
Identification of proteins in agarose gel SPE 
To identify the proteins present in the globulin fractions, 13 bands were cut from the agarose gels 
(figures 2a to 2d), 8 from two control cats (A-H) and 5 from a cat with lymphoma (I-M). In each 
fraction/band, multiple proteins were identified and are listed by name and by NCBI accession 
number in table 3. The species in which these protein sequences were previously identified is 
also listed. The percentage of the protein’s sequence covered by the identified peptides, Matrix 
Science MOWSE scores and the number of peptides matched are given as indicators of the 
closeness of the match. The bands (in figure 2) in which each protein was identified and the type 
of case from which it was excised (control or lymphoma) is also given.  The fractions in which 
these proteins have been previously reported in the feline and human literature are also listed 
with their corresponding references.11,12,13  Eleven proteins were identified from the feline protein 
database. It can be seen that some proteins were only identified in either the control cats or the 
lymphoma cat (table 3) although these differences should be interpreted with caution due to the 
small number of cases analysed. A summary of the proteomic analysis findings with regards to 
the position of some of the most clinically relevant proteins can be seen in figure 1. 
 
Proteomic analysis of the 4 additional bands of high relative intensity in the lymphoma group 
(bands N, O, P and Q, figure 2, table 4) showed that.band N (α2 globulin) from cat 4 contained 
several proteins including haptoglobin and an isoform of ceruloplasmin (acute phase proteins). 
Bands P (β2 globulin) and Q (γ globulin) contained various immunoglobulins and examination of 
the electrophoretograms (figure 3a and 3b) revealed narrow spikes in these regions suggestive of 
monoclonal or oligoclonal gammopathies.26 Hemoglobin proteins were identified from band O 
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(lymphoma cat 10) suggesting the sample was hemolysed. This sample was slightly red-tinged 
on gross appearance. 
 
Discussion 
Serum protein electrophoresis 
This study compared serum protein electrophoretic patterns from a group of normal cats to those 
from a group of untreated cats diagnosed with lymphoma. No consistent electrophoretic pattern of 
globulins was found in the cats with lymphoma but the lymphoma population studied was 
heterogeneous and so in retrospect, this might have been expected. Production of 
immunoglobulins is not common in feline lymphoma, except for some B cell cases or if secondary 
infection is present and so this may also have accounted for a lack of consistent differences. The 
relatively small number of cats may have contributed to insufficient power of the study making 
consistent changes difficult to determine.  
Although the total number of identifiable electrophoretic peaks was not significantly different 
between the two groups, there was a significantly lower median absolute albumin concentration 
and higher median absolute concentration of β globulins in cats with lymphoma. Albumin is a 
negative acute phase protein and so the decrease in the lymphoma cats would be consistent with 
an acute phase response. A significant increase in the α-1 and α-2 globulins (fractions reported to 
contain positive acute phase proteins in people and cats,11,12,13) in the lymphoma cats was not 
found however, despite the elevated concentration of Hp and AGP in lymphoma cats compared 
to controls on serum assays. This discrepancy may be because these proteins may not be easily 
detected by SPE on agarose gels or more likely, because these proteins represent only a small 
proportion of the overall α-globulins even when their concentration is dramatically increased. An 
alternative explanation for the lower median serum albumin in the lymphoma cats could be 
gastrointestinal or renal albumin loss (5 cases had gastrointestinal lymphoma with additional 
renal lesions in 1 of these cats) or reduced hepatic albumin production. Tests to assess these 
causes of reduced albumin were not performed in the majority of cases in this study.  
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The significant elevation in β globulins in the lymphoma cats was attributed to two cats in 
particular which had very high total β globulins, despite total protein being normal. The 
proteomics results provide information as to the nature of these proteins and in one cat they were 
the result of hemolysis (cat 10) and in the other cat (cat 14) due to a band containing IgM 
heavy/constant chains. If the animal with hemolysis is excluded from the analysis (artefactual 
elevation), the median concentration of β-globulins is still significantly different in the lymphoma 
cats (P=0.031), however, if both are excluded, the difference is not significant. Further 
investigation with a larger number of cats would confirm whether a consistent elevation in median 
β-globulin concentration occurs in cats with lymphoma. 
 
Proteomic analysis 
Full proteomic analysis of the SPE fractions of 2 normal cats and one lymphoma cat was carried 
out to identify some of component proteins which make up the different globulin bands. As 
expected, multiple proteins were identified from each fraction even in a single cat, 27 (table 3). 
TMFA enabled us to match peptide fragments to mammalian protein databases. MOWSE scores 
above 48 indicate matching with greater than 95% confidence; matches above this threshold are 
listed in table 3 and the great majority of proteins listed are matched at significantly higher 
confidence. Although many of the matched proteins were encoded by mammalian genomes other 
than Felis catus, this is likely because the homologous genome sequence is not yet available for 
cats and our results suggest that the cat homologues of these proteins are indeed present in our 
samples. The large number of proteins identified in each fraction partly reflects the limited 
separation achieved on agarose gels and also the large size of some of the excised bands 
submitted for TMFA.  It should be noted that occasionally the peptide fragments match valid 
sequences in very closely related proteins accounting for some apparent repetition in table 3 eg 
apolipoprotein A-1 precursor, proapolipoprotein and apoplipoprotein E4.  Additionally some poorly 
characterized proteins are listed eg leucine-rich repeat kinase 1, zinc finger protein 85 although 
their clinical significance is as yet unknown. 
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Some of the more clinically relevant proteins identified by TMFA of bands A-M are shown in figure 
1C with the corresponding fractions in which they are found. Many of these are serum proteins, 
with a function in inflammation and the acute phase response eg negative APP such as albumin 
and serotransferrin (part of transferrin superfamily) and positive APP such as AGP, Hp and 
ceruloplasmin.28 Serum measurements of AGP and Hp revealed that both these APP were higher 
in the lymphoma cat population compared to controls, however, ceruloplasmin was not assayed. 
Ceruloplasmin and Haptoglobin were also identified in band N (lymphoma cat 4) in the α2 region 
where they have previously been identified.11,13 A significant elevation of AGP but not Hp has 
been reported previously in lymphoma cats, 21 and elevations of AGP, 29, 30 and C-reactive protein 
CRP, 31, 32 have been reported in dogs with lymphoma.  Additional proteins associated with 
inflammation and immune reactions included complement, immunoglobulins and the soluble form 
of fibronectin which may be involved in clearance of complement and immune complexes from 
the circulation.33 Also identified were various serum enzymes (plasminogen) and enzyme 
inhibitors (alpha-2 macroglobulin, antithrombin III) involved in control of coagulation and tissue 
damage. Haemoglobin, hemopexin and albumin which bind iron-containing heme, and iron 
transporters such as serotransferrin and lactoferrin  were also present as were various 
apolipoproteins  (lipid transport proteins). Many of these proteins were also present in the 
corresponding fractions in the isolated intense bands from lymphoma cats eg alpha-2 
macroglobulin in band N (α2 globulin), hemopexin in band O (β globulin). 
 
In addition to these well known serum proteins, there was also the identification of a less well 
known protein, inter-α (globulin) inhibitor H4 in bands K, F, G, L and M (from both cats with and 
without lymphoma). This protein is known to be an acute phase protein in pigs,34,35  with the name 
of pig-MAP and is also known as plasma kallikrein-sensitive glycoprotein. It has also been 
identified in humans,36,37  but has not been described in the cat. Discovery of this previously 
unsuspected protein from the feline SPE highlights one advantage of proteomics over 
immunoelectrophoresis since the latter can only be used to look for previously known proteins 
and only if an appropriate antibody exists. 
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In most cases, the proteins were identified by proteomic analysis from bands excised from 
fractions in (or close to) the fractions in which they are expected to be found (table 3).11,12,13  
Many proteins (eg serotransferrin and inter-α (globulin) inhibitor H4) were found to have a wider 
distribution across the SPE fractions than expected from the literature.11,12,13,14 This may reflect 
the presence of different protein isoforms (due to genetic variation or changes in protein 
glycosylation patterns,4,14) or of protein fragments (formed by storage, protein extraction or protein 
digestion) with different isoelectric points. The presence of albumin in the gamma fraction may be 
a result of precipitation of this protein at the application site (“X” figure 2).   
 
In each fraction, many proteins were identified in either the control cats or the lymphoma cat 
(table 3, figure 1), although these differences should not be given much emphasis, considering 
the preliminary nature of this study and the very few cases analysed. However, lack of detection 
of a protein in control or lymphoma cats may have been due to a refractory response to trypsin 
digestion and/or generation of peptides that ionize poorly. In the case of some proteins, the 
difference may be because they are only synthesized in either normal or lymphoma cats or their 
synthesis is up or down regulated in disease, eg the acute phase protein AGP, was only identified 
in the cat with lymphoma. It is also possible that these proteins were present in both affected and 
non-affected cats but due to the small number of cats in this preliminary comparison, the proteins 
were not matched in both types of case. Another possibility is that although the proteins were 
present in both types of cat, the protein migration differed and the proteins were identified in 
different fractions (eg IgG1 heavy chain).  
 
The TMF analysis was particularly helpful in identifying constituent proteins of highly intense 
bands in the beta/gamma globulin region of three lymphoma cats (5, 10, 14). In cat 10 (band O) 
hemoglobin proteins suggested hemolysis was the cause of this electrophoretic peak. In the other 
two cats (5 and 14, figure 3), immunoglobulins were identified (table 4). The narrow spikes on the 
electrophoretograms in these two cats are suggestive of monoclonal or oligoclonal 
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gammopathies, rather than polyclonal and further testing with immunoelectrophoresis might have 
differentiated the type of immunoglobulin.26 On routine biochemical testing cat 14 had mildly 
elevated globulin concentration (50g/l, reference range: 27-45g/l) but normal total protein. On 
electrophoresis, beta globulins (45.5g/l) were highly elevated emphasising the need for SPE 
analysis in such cases. TMFA identified IgM as the predominant protein in band P (table 4) highly 
suggestive of a monoclonal gammopathy in the β2 fraction.19 In cat 5, total proteins and globulins 
on biochemical analysis and the gamma fraction on electrophoresis were normal. TMFA identified 
IgG as the strongest matching protein in band Q.  
 
The inclusion of a relatively small and heterogeneous group of cats with lymphoma with various 
anatomic forms, immunophenotypes and durations of clinical signs prior to presentation is a 
limitation of this study. This was likely to have had an effect on the results of comparisons 
between the SPE profiles of the lymphoma and control cats. If a more homogeneous population 
were examined, a more consistent pattern might have emerged. The results of the proteomic 
identification of protein components within the fractions was likely to have been affected by the 
inclusion of only 3 cats, and potential bias in the way these 3 cases were selected. However this 
was only a preliminary investigation to illustrate the potential of TMFA in this clinical application 
and we have successfully demonstrated that this technique can be used to further analyse the 
constituent proteins of the SPE fractions. A more complete proteomic comparison would have 
required 2D-PAGE separation followed by TMFA and a larger number of cats. 
 
To conclude, this study has shown that feline lymphoma patients have lower median albumin 
concentrations and higher beta globulin concentrations than control cats but identified no 
consistent elevations in gamma globulins or characteristic electrophoretic patterns. It has 
established that the protein bands excised from SPE agarose gels can be identified by LC-MS 
and confirmed previous findings,11 about the migration pattern of proteins found in the individual 
fractions following SPE of feline serum on agarose gels. Inter-α (globulin) inhibitor H4, a protein 
that has not previously been recognized in cats, was identified.  
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Figure Legends 
Figure 1: Example of the serum protein electrophoresis gel (A) and electrophoretogram (B) for a 
cat (control cat 3) with 8 identifiable fractions. The y-axis represents the optical density of the 
band on the gel and the x-axis represents the distance along the gel. The table (C) shows a 
summary of the position of some of the most clinically relevant proteins as identified by the 
tandem mass fingerprinting analysis following excision of bands from the electrophoretic gels of 
control cats 2 and 3 and lymphoma cat 7. 
  
Figure 2: Agarose electrophoresis gels (A to D) from all cats included in the study. Each lane 
represents serum from a different cat, either control or lymphoma. The final lane on each gel is a 
control sample (human). ●X represents the application site on the gel. The boxes labeled A to Q 
represent the areas excised from the gels for peptide fingerprinting analysis and correspond to 
the 9th column on table 3 (A to M), entitled “Excised band from which found” and the subheadings 
on table 4. The line marked by an asterisk is thought to be caused by precipitation at the origin on 
this particular gel. The FeLV and FIV positive cats are identified on the figures. The B or T cell 
immunophenotype are given for those cats in which this is known or labeled as IPU 
(immunophenotype unknown) where not done. 
 
Figure 3: Electrophoretograms of lymphoma cats 5 (fig 3A) and 14 (fig 3B) from which bands Q 
and P were excised showing the narrow-based “spikes”. The y-axis represents the optical density 
of the band on the gel and the x-axis represents the distance along the gel. The shaded area 
represents the area excised for proteomic analysis, the results of which are shown in table 4. 
 
 
Table 1 Clinical details of lymphoma cats
Lymphoma 
cat number
FeLV 
status
FIV 
status Anatomical site
Method of 
diagnosis Immunophenotype
1 negative negative gastrointestinal (with renal involvment) cytology Unknown
2 negative negative gastrointestinal histopathology B cell
3 positive negative thymic histopathology T cell
4 negative negative multicentric histopathology Unknown
5 negative negative extranodal (laryngeal) histopathology Unknown
6 negative negative multicentric (with thymic involvment) cytology Unknown
7 negative negative thymic cytology Unknown
8 negative negative extranodal (pulmonary) cytology Unknown
9 negative positive extranodal (laryngeal) cytology Unknown
10 negative positive gastrointestinal histopathology Unknown
11 negative negative gastrointestinal histopathology T cell
12 negative negative thymic cytology T cell
13 negative negative multicentric histopathology B cell
14 negative negative gastrointestinal histopathology Unknown
Table 2: Relative and absolute values of albumin and globulin concentrations in lymphoma and control cats 
 
  Number of Samples 
Median Relative Values (%) 
(range)  
Median absolute values (g/l) 
(range) 
Fractions 
Control 
cats 
Lymphoma 
cats Control cats 
Lymphoma 
cats Control cats 
Lymphoma 
cats p value 
74.5 74.5 
Total protein 14 14 
NA  NA 
(67.0 – 86.0) (53.0 – 89.0) 0.80 
40.6 35.4 29.1 24 
Albumin 14 14 (26.7-48.5)  (23.3-50.2) (19.8 – 37.3) (19.3-44.7) 0.046 
0.7 0.6 
Albumin to globulin ratio 14 14 
NA  NA 
(0.4– 0.9)  (0.3 – 0.7) 0.14 
10.3 10.2 7.7 7.5 
Alpha-1 globulins total 14 14 (8.6 – 15.1) (6.0 – 13.9) (6.9 – 10.4) (5.0 – 11.1) 0.24 
6.3 6.0 4.8 4.2 
Alpha-1a globulins 12 12 (3.4 – 9.4) (2.4 – 8.1) (2.9 – 6.5) (2.0 – 6.6) 0.44 
3.9 4.3 3.0 3.0 
Alpha-1b globulins 12 12 (2.9 – 8.4) (3.0 – 6.1) (2.5 – 5.8) (2.4 – 4.5) 0.95 
18.9 16.7 13.4 12.4 
Alpha-2 globulins total 14 14 (7.46 – 23.0) (10.2 – 25.2) (5.3 – 17.8) (7.8 – 21.4) 0.32 
12.1 15.0 9.1 9.5 
Alpha-2a globulins 4 6 (6.7 – 13.1) (5.8 – 18.4) (5.8 – 9.5) (4.6 – 15.7) 0.76 
6.7 6.6 5.4 4.6 
Alpha-2b globulins 4 6 (6.0 – 10.2) (6.2 – 9.9) (4.3 – 7.6) (3.8 – 7.9) 0.61 
10.3 15.0 7.8 11.4 
Beta globulins total 14 14 (7.6 – 23.2) (11.8 – 45.5) (5.7 – 16.0) (7.3 – 45.5) 0.02 
6.2 8.4 4.7 4.7 
Beta-1 globulins 5 12 (5.5 – 9.5) (3.9 – 10.4) (4.4 – 6.8) (2.5 – 7.7) 0.96 
7.52 7.0 5.4 5.1 
Beta-2 globulins 5 12 (5.1 – 13.7) (4.1 – 40.0) (3.7 – 9.5) (2.4 – 29.2) 0.43 
21.5 19.6 17.2 14.1 
Gamma globulins 14 14 (6.9 - 37.4) (8.4 – 30.9) (4.8 – 27.6) (5.0 – 21.9) 0.28 
 
NA – not applicable. 
Values shown in bold were statistically significantly different (p<0.05) 
Sub-
fraction 
on SPE Proteins identified
Accession 
Number Species of Origin
Sequence 
coverage 
(%)
MOWSE 
Score
Number 
of 
peptides 
matched
Type of 
case(s) in 
which peptide 
found
Excised 
band in 
which 
found
Fraction reported in 
literature
Albumin fraction
NA serum albumin precursor gi|57977283 Felis catus 53 1851 40 control A albumin/ α-1 (11, 13)
NA apolipoprotein A-I gi|342075 Macaca fascicularis 11 136 3 control A albumin/ α-1 (11,13)
Alpha-1a globulin fraction
NA serum albumin precursor gi|57977283 Felis catus 30 967 20 control + LSA B, I albumin/ α-1 (11, 13)
NA apolipoprotein A-1 gi|342075 Macaca fascicularis 21 209 7 control + LSA B, I albumin/ α-1 (11,13)
NA IgG1 heavy chain gi|3402543 Felis catus 11 110 2 LSA I β/ γ (11,12, 13)
NA inter-alpha (globulin) inhibitor H3* gi|74011920 Canis lupus familiaris 4 63 3 control B NR
Alpha-1b globulin fraction
NA alpha-2-macroglobulin precursor* gi|73997689 Canis lupus familiaris 4 250 8 control C α-2 (11, 12, 13)
NA serum albumin precursor gi|57977283 Felis catus 15 361 8 LSA J albumin/ α-1 (11, 13)
NA apolipoprotein A-I precursor* gi|73955106 Canis lupus familiaris 19 235 7 control + LSA C, J albumin/ α-1 (11,13)
NA proapolipoprotein gi|178775 Homo sapiens 22 192 5 LSA J NR
NA apolipoprotein E4 gi|283972743 Panthera tigris 14 76 3 control C NR
NA vitamin D-binding protein* gi|114594352 Pan troglodytes 8 102 3 LSA J NR
NA alpha-1 acid glycoprotein gi|47825211 Felis catus 9 79 3 LSA J α-1 (11, 13)
NA inter-alpha-trypsin inhibitor heavy chain H2 gi|3024062 Mesocricetus auratus 1 60 2 control C α-2 (13)
NA serotransferrin precursor (transferrin) (siderophilin)* gi|73990142 Canis lupus familiaris 2 55 1 LSA J β (11, 12, 13)
NA protein AMBP (alpha-1-microglobulin) (inter-alpha-trypsin inhibitor light chain) gi|72507586 Homo sapiens 2 51 1 LSA J α-2 (13)
Alpha-2 globulin fraction
a + b alpha-2-macroglobulin precursor* gi|73997689 Canis lupus familiaris 7 568 10 control + LSA D, E, K α-2 (11, 12, 13)
a + b pregnancy zone protein* gi|73997687 Canis lupus familiaris 3 234 5 control D, E NR
a + b haptoglobin gi|73990923 Felis catus 35 169 4 control + LSA D, E, K α-2 (11, 13)
b IgG1 heavy chain gi|3402543 Felis catus 18 153 5 control E β/ γ (11,12, 13)
NK apolipoprotein A-I precursor* gi|73955106 Canis lupus familiaris 19 152 5 LSA K albumin/ α-1 (11,13)
b hemoglobin subunit beta gi|122594 Crocuta crocuta 22 147 3 control E β (13)
b + NK complement component C3 gi|47522844 Sus scrofa 2 146 3 control + LSA E, K β-2 (11, 13)
b beta-globin gi|22874 Gorilla gorilla 19 125 2 control E NR
NK inter-alpha (globulin) inhibitor H4 (plasma kallikrein-sensitive glycoprotein)* gi|74011918 Canis lupus familiaris 4 112 4 LSA K α-2 (13)
b antithrombin III gi|179161 Homo sapiens 7 109 2 control E α-2 (11)
NK proapolipoprotein gi|178775 Homo sapiens 18 104 4 LSA K NR
a + b clusterin precursor gi|50979240 Canis lupus familiaris 4 90 2 control D, E NR
b Haemoglobin subunit epsilon gi|122725 Otolemur crassicaudatus 15 88 2 control E NR
NK inter-alpha-trypsin inhibitor family heavy chain-related protein gi|1483187 Homo sapiens 1 84 2 LSA K α-2 (13)
b alpha-2-HS-glycoprotein precursor (Fetuin-A) (alpha-2-z-globulin) isoform 2 gi|740003450 Canis lupus familiaris 5 83 2 control E NR
NK apolipoprotein B precursor gi|553189 Homo sapiens 1 79 2 LSA K NR
b apolipoprotein J precursor gi|178855 Homo sapiens 4 78 2 control E NR
b serotransferrin precursor (transferrin) (siderophilin)* gi|73990108 Canis lupus familiaris 4 70 2 control E β (11, 12, 13)
a leucine-rich repeat kinase 1* gi|109082322 Macaca mulatta 1 68 3 control D NR
b A-gamma globin gi|284005431 Oryctoacus cuniculus 16 64 2 control E NR
b apolipoprotein A-IV* gi|149716543 Equus caballus 2 64 1 control E NR
NK RIKEN cDNA 1300017J02 gi|18204720 Mus musculus 1 62 1 LSA K NR
a + b ceruloplasmin gi|1224108 Mus musculus 3 59 3 control D, E α-2 (11,13)
b porcine inhibitor of carbonic anhydrase* gi|194221612 Equus caballus 1 58 1 control E NR
a kininogen 1* gi|57109938 Canis lupus familiaris 2 54 1 control D NR
a kininogen 2 isoform 1 gi|41235784 Mus musculus 1 53 1 control D NR
NK melanoma associated antigen (mutated) 1-like 1* gi|74009138 Canis lupus familiaris 2 53 2 LSA K NR
a murinoglobin 1 precursor gi|12831225 Rattus norvegicus 1 53 2 control D NR
a zinc finger protein 85 (HPF4, HTF1)* gi|149626477 Ornithorhynchus anatinus 3 51 2 control D NR
b anionic trypsin-1 precursor gi|6981420 Rattus norvegicus 8 50 1 control E NR
Table 3: LC-MS identification of proteins from excised albumin and globulin fractions (bands A-M figure 2) following  protein electrophoresis of feline serum
Sub-
fraction 
on SPE Proteins identified
Accession 
Number Species of Origin
Sequence 
coverage 
(%)
MOWSE 
Score
Number 
of 
peptides 
matched
Type of 
case(s) in 
which peptide 
found
Excised 
band in 
which 
found
Fraction reported in 
literature
Beta globulin fraction
1 + 2 serotransferrin precursor (transferrin) (siderophilin)* gi|73990142 Canis lupus familiaris 16 610 11 control + LSA F, G, L β (11, 12, 13)
1 + 2 complement C3 precursor* gi|194212541 Equus caballus 7 386 10 control F, G β-2 (11, 13)
1 + 2 hemopexin* gi|73988725 Canis lupus familiaris 14 278 6 control + LSA F, G, L β (11, 12, 13)
1 + 2 fibronectin* gi|194211292 Equus caballus 2 231 6 control + LSA F, G, L NR
1 + 2 inter-alpha (globulin) inhibitor H4 (plasma kallikrein-sensitive glycoprotein)* gi|194221223 Equus caballus 5 194 5 control + LSA F, G, L α-2 (13)
2 IgG1 heavy chain gi|3402543 Felis catus 17 180 4 control G β/ γ (11,12, 13)
2 + NK lactoferrin gi|186833 Homo sapiens 3 143 4 control + LSA G, L NR
1 + 2 lactotransferrin isoform 3* gi|73985785 Canis lupus familiaris 4 131 4 control F, G NR
1 inter-alpha (globulin) inhibitor H1* gi|194211292 Equus caballus 4 126 4 control F NR
1 PK-120 precursor gi|2739028 Mus musculus 2 117 3 control F NR
1 trypsin inhibitor gi|33985 Homo sapiens 2 101 4 control F NR
1 + NK inter-alpha -trypsin inhibitor family heavy chain-related protein gi|1483187 Homo sapiens 1 97 2 control + LSA F, L α-2 (13)
1 alpha-2 macroglobulin precursor* gi|73997689 Canis lupus familiaris 2 94 2 control F α-2 (11, 12, 13)
2 + NK complement component C4A gi|179674 Homo sapiens 1 93 2 control + LSA G, L β (11)
2 immunoglobulin kappa light chain gi|6456731 Felis catus 8 87 2 control G β/ γ (11, 13)
2 IgM heavy chain gi|3402547 Felis catus 5 78 3 control G β/ γ (11, 13)
NK proapolipoprotein gi|178775 Homo sapiens 10 77 2 LSA L NR
2 Immunoglobulin heavy chain VHDJ region gi|38092744 Camelus dromedarius 14 71 1 control G NR
1 apolipoprotein B precursor gi|553189 Homo sapiens 1 71 2 control F β (11)
1 + 2 apolipoprotein A-1 gi|3915607 Canis lupus familiaris 6 71 2 control + LSA F, G, L albumin/ α-1 (11,13)
1 antithrombin III gi|179161 Homo sapiens 6 71 2 control F α-2 (11)
2 plasminogen gi|18139619 Canis lupus familiaris 4 70 2 control G β (11)
2 IgG gamma constant chain gi|2914001 Felis catus 19 70 2 control G β/ γ (11,12, 13)
1 + 2 alpha-2 plasmin inhibitor gi|219408 Homo sapiens 6 66 1 control F, G NR
2 sex hormone-binding globulin gi|38325826 Bos taurus 3 62 1 control G NR
2 immunoglobulin lambda-chain gi|192812 Mus musculus 7 61 1 control G NR
NK CHKSR family member 3 gi|197098578 Pongo abelii 2 58 3 LSA L NR
NK IgM constant chain gi|2914011 Felis catus 4 56 1 LSA L β/ γ (11, 13)
2 anionic trypsin-1 precursor gi|6981420 Rattus norvegicus 8 55 1 control G NR
NK hepatocarcinogenesis-specific protein/hemopexin homolog (clone HC34) gi|1087020 Marmota monax 3 53 1 LSA L NR
Gamma globulin fraction
NA IgG1 heavy chain gi|3402543 Felis catus 42 524 16 control + LSA H, M β/ γ (11,12, 13)
NA immunoglobulin kappa light chain gi|6456731 Felis catus 34 291 6 control + LSA H, M NR
NA IgM heavy chain gi|3402547 Felis catus 17 229 5 control + LSA H, M β/ γ (11, 13)
NA immunoglobulin heavy chain variable region gi|37694585 Homo sapiens 16 169 3 control + LSA H, M NR
NA Ig heavy chain variable region, VH3 family gi|33319108 Homo sapiens 24 107 3 control + LSA H, M NR
NA immunoglobulin heavy chain VHDJ region gi|38093044 Camelus dromedarius 16 84 1 control + LSA H, M NR
NA immunoglobulin lambda chain gi|192812 Mus musculus 7 81 1 control + LSA H, M NR
NA NUAK family, SNF1-like kinase, 2* gi|291402539 Oryctolagus cuniculus 1 80 2 control H NR
NA immunoglobulin epsilon heavy chain constant region gi|7262603 Felis catus 3 78 2 control + LSA H, M NR
NA albumin gi|309262111 Felis catus 2 68 2 control + LSA H, M albumin/ α-1 (11, 13)
NA inter-alpha (globulin) inhibitor H4 (plasma kallikrein sensitive glycoprotein)* gi|126336622 Monodelphis domestica 2 68 2 LSA M α-2 (13)
NA complement factor H precursor (H factor 1) isoform 2 gi|74005944 Canis lupus familiaris 1 67 1 control H NR
NA serotransferrin precursor (transferrin) (siderophilin)* gi|73990142 Canis lupus familiaris 2 59 1 control + LSA H, M β (11, 12, 13)
NA immunoglobulin lambda-like polypeptide 1 precursor (immunoglobulin-related 14gi|73995675 Canis lupus familiaris 22 57 2 control H NR
NA immunoglobulin V lambda/J lambda light chain gi|6643739 Homo sapiens 17 49 2 LSA M NR
* NCBI record for these proteins are predicted from the genomic sequence
proteins in bold text are those identified in Felis catus
NA Not applicable
NK sub-fraction not known
LSA Lymphoma
NR migration not reported in human or feline literature
Table 4: LC-MS identification of proteins from specific excised isolated bands (bands N to Q, figure 2)  following protein electrophoresis of feline serum
Fraction 
on SPE Proteins identified Species of Origin
Accession 
Number
Sequence 
coverage 
(%)
MOWSE 
Score
Number of
peptides 
matched
 
Protein 
present in 
control 
cats in 
this 
fraction?
Protein 
present in 
lymphoma 
cat 7 in 
this 
fraction?
BAND N (figure 2)
alpha 2a
haptoglobin Felis catus gi|73990923 35 175 6 Yes Yes
pregnancy-zone protein* Canis lupus familiaris gi|73997687 2 158 4 Yes No
ceruloplasmin (ferroxidase) isoform 2* Macaca mulatta gi|109048806 4 101 3 Yes No
alpha-2 macroglobulin precursor* Canis lupus Familiaris gi|73997689 1 97 3 Yes Yes
hemoglobin beta chain Macaca arctoides gi|86611 23 75 3 No No
DEAH (Asp-Glu-Ala-His) box polypeptide 37 Monodelphis domestica gi|126323968 1 48 2 No No
BAND O (figure 2)
beta
haemoglobin subunit beta-2 panthera pardus saxicolor gi|55584062 67 420 13 No No
haemoglobin subunit beta A/B Felis catus gi|122608 75 374 13 No No
haemoglobin subunit alpha Felis catus gi|122405 46 220 10 No No
beta globin Orycteropus afer gi|221381007 14 144 3 No No
serotransferrin precursor (transferrin) isoform 1* Canis lupus Familiaris gi|73990142 7 116 5 Yes Yes
alpha globin chain Mesocricetus auratus gi|49421 20 106 4 No No
haemoglobin subunit epsilon Bradypus tridactylus gi|78099200 21 101 4 No Yes
hemopexin* Canis lupus familiaris gi|73988725 6 82 2 Yes Yes
apolipoprotein A-I Canis lupus familiaris gi|3915607 6 58 2 Yes No
lactotransferrin isoform 3* Canis lupus Familiaris gi|73985785 2 50 2 Yes No
BAND P (figure 2)
beta2
IgM heavy chain Felis catus gi|3402547 45 602 15 Yes No
serotransferrin precursor (transferrin) isoform 1* Canis lupus Familiaris gi|73990142 7 156 5 Yes Yes
immunoglobulin heavy chain variable region Homo sapiens gi|118405920 15 73 2 Yes No
Ig mu chain C region membrane-bound form Oryctolagus cuniculus gi|127511 3 61 2 No No
NUAK family, SNF1-like kinase, 2* Oryctolagus cuniculus gi|291402539 1 60 2 No No
SNF histone linker PHD RING helicase* Monodelphis domestica gi|126310663 0 56 2 No No
Ig heavy chain variable region, VH3 family Homo sapiens gi|33319108 15 50 2 Yes No
BAND Q (figure 2)
gamma
IgG1 heavy chain Felis catus gi|3402543 27 177 6 Yes Yes
immunoglobulin heavy chain variable region Homo sapiens gi|118405920 15 62 1 Yes Yes
IgM heavy chain Felis catus gi|3402547 7 58 2 Yes Yes
titin* Equus caballus gi|194222358 0 48 6 No No
* NCBI record for these proteins are predicted from the genomic sequence
proteins in bold text are those identified in Felis catus
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